CAS: 1009821-06-0
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid REF: IN-DA0003DDCAS: 1009821-06-0 | - - - | A consultar | Qui 05 Dez 24 | |
5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid REF: 3D-JQB82106CAS: 1009821-06-0 | Min. 95% | A consultar | Qui 16 Jan 25 | |
CX-5011 REF: TM-T71627CAS: 1009821-06-0 | 98% | 907,00 €~2.337,00 € | Qui 23 Jan 25 | |
5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid REF: 10-F600227CAS: 1009821-06-0 | 95+% | - - - | Produto descontinuado |
5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid
CAS:1009821-06-0
Fórmula:
C20H12N4O2
Peso molecular:
340.3349
Ref: IN-DA0003DD
Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 5 de Dezembro de 2024
5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid
CAS:1009821-06-0
The 5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid is a ligand that has been used as a research tool to …
Fórmula:
C20H12N4O2
Pureza:
Min. 95%
Peso molecular:
340.3 g/mol
Ref: 3D-JQB82106
5g | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 16 de Janeiro de 2025
CX-5011
CAS:1009821-06-0
CX-5011, a CK2 inhibitor, induces Rac1 activation and promotes apoptosis, effectively causing cancer cell death …
Fórmula:
C20H12N4O2
Pureza:
98%
Cor e Forma:
Liquid
Peso molecular:
340.33
Ref: TM-T71627
25mg | 1.410,00 € | ||
50mg | 1.851,00 € | ||
100mg | 2.337,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 23 de Janeiro de 2025
5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid
CAS:1009821-06-0
Pureza:
95+%
Peso molecular:
340.3420104980469
Ref: 10-F600227
1g | Descontinuado | Solicitar informações |